CONTRIBUTING SINCE SEPTEMBER 2008

McGuireWoods LLP

POPULAR TOPICS

Food, Drugs, Healthcare, Life Sciences Corporate/Commercial Law Litigation, Mediation & Arbitration Consumer Protection Antitrust/Competition Law

McGuireWoods LLP are most popular:

within Coronavirus (COVID-19) topic(s)

DETAILS

United States

www.mcguirewoods.com

+1 212 548 2189

1345 Avenue of the Americas, 7th Floor

800 East Canal Street

New York

United States

COMPANY CONTENT

Trump Halts Offshore Wind Leasing And Federal Permitting For Wind Projects

United States Energy

Trade Secrets: What You Should Know From 2024 To Prepare For 2025

United States IP

Presidential Executive Order Targets DEI In Higher Education

United States Consumer

Second Circuit Joins Other Circuits With AKS One Purpose Test

United States Healthcare

Trump, Tech Leaders Announce AI Infrastructure Investment Plan, Boon To Data Center Industry

United States Real Estate

New Executive Order Revokes Executive Order 11246 And Targets Employer DEI Efforts

United States Government

Why Doesn't The Crime-Fraud Exception More Frequently Swallow The Attorney-Client Privilege?

United States Criminal

FDA Bans Red Dye No. 3 In Food And Drugs, Sets Deadlines For Manufacturers To Reformulate

United States Healthcare

DOJ, FTC Issue Updated Antitrust Guidance For Employers On Business Activities Affecting Workers

United States About Mondaq

DOJ Seeks Supreme Court Review Of CTA Injunction

United States Litigation

Cautionary Tale: Contractor Settles For $2.6M Over Alleged Falsely Obtained Small Business Contracts

United States Government

Life Sciences Investors: Developments To Watch, With Kevin Madagan (Podcast)

United States Healthcare

Department Of Education OCR Issues Guidance On How Schools Analyze NIL Activity Under Title IX

United States Consumer

Contaminants Compass: January 2025 Edition

United States Environment

Healthcare & Life Sciences Private Equity Deal Tracker: New Mountain To Acquire Machinify

United States Healthcare

When Can A Litigant Overcome The Adversary's Fact Work Product Protection?

United States Litigation

Federal Circuit: Published Patent Applications Available As Prior Art In IPRs As Of Filing Date

United States IP

FTC Announces 2025 Thresholds For Hart-Scott-Rodino Premerger Filings And Fees

United States Anti-trust

New Year, New (Anticipated) Federal Immigration Policy: Steps Employers Can Take Now To Prepare

United States Immigration

Healthcare & Life Sciences Private Equity Deal Tracker: Renovus Acquires Superior Health

United States Healthcare

AUTHORS

Last Article 29 Jan 2025

Emilie J. McNally

Last Article 29 Jan 2025

Edmund D. Daniels

Last Article 29 Jan 2025

David A. Franchina

Last Article 29 Jan 2025

Christopher M. Keegan

Last Article 29 Jan 2025

Clint A. Roscoe

Last Article 29 Jan 2025

Last Article 29 Jan 2025

Heather Nixon Stevenson

Last Article 29 Jan 2025

McGuireWoods LLP

Last Article 29 Jan 2025

Last Article 28 Jan 2025

Last Article 28 Jan 2025

Farnaz F. Thompson

Last Article 28 Jan 2025

Michael J. Podberesky

Last Article 28 Jan 2025

Last Article 28 Jan 2025

Last Article 28 Jan 2025

Michael Dingman

Last Article 28 Jan 2025

Christopher Thatch

Last Article 28 Jan 2025

Gregory A. Riegle

Last Article 28 Jan 2025

Edwin Childs Jr.

Last Article 28 Jan 2025

William E. Doyle Jr.

Last Article 28 Jan 2025

AWARDS

Spring 2025 Award for Environmental Law in United States

Environmental Law

Contaminants Compass: December 2024 Edition

Spring 2025 Award for Energy and Natural Resources in United States

Energy and Natural Resources

Contaminants Compass: December 2024 Edition

Autumn 2023 Award for Food, Drugs, Healthcare, Life Sciences in United States

Food, Drugs, Healthcare, Life Sciences

Washington Healthcare Update | July 17, 2023

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More